injectable hgh for sale
Summary of current status of sales for injectable hgh
Approximate manufacturing cost and pricing details for injectable hgh
Injectable hgh would represent a similar product in terms of manufacturing cost and pricing to current injectable steroids (Oxymorphone) and would increase the total market for injectable steroids (providing both injectables and hgh) from ~1.7 billion USD to ~3.6 billion USD in five years.
Approximately 40%-50% of injectable hgh (or injectable hgh units) could be used as oral doses while the remaining 50%-60% would likely be used as hgh injections (50% oral and 50% injection) (See Table 2 for relative dosage for injectable hgh). It is important to note that it is reasonable to assume that many patients would likely prefer injections over oral or topical products (based on anecdotal observation). The injectable hgh for sale units are likely to be used to treat selected therapeutic indications in non-inflammatory diseases of aging (see Table 2 for potential indications). These treatments would likely be used to treat conditions such as hypertension, high cholesterol, cardiomyopathy, osteoporosis, arthritis, fibromyalgia, spinal pain, acne, and obesity. In addition, it is likely that injectable hgh would represent an important intervention for the treatment of congestive heart failure, non-infectious low blood pressure, epilepsy, hypertension, cardiovascular diseases in postmenopausal women, and infections (e.g., hepatitis C infection).
Sales of injectable hgh (or injectable hgh units) would represent a substantial market (more than one billion USD for injectable hgh products) in five years (or 12 months). This estimate is based upon projected sales of injectable hgh products in five years (or 12 months) in the United States alone and may be based upon the following assumptions: 1. Adverse reactions and mortality due to injectable hgh would be less than 10% (vs. 20%-30% of current injectable steroids